Randomized Study of Basal-Bolus Insulin Therapy in the Inpatient Management of Patients With Type 2 Diabetes Undergoing General Surgery (RABBIT 2 Surgery)
Open accessThe DOI matches its Crossref record; 24 of the 24 references it cites were found in a registry or an index.
Abstract
OBJECTIVE: The optimal treatment of hyperglycemia in general surgical patients with type 2 diabetes mellitus is not known. RESEARCH DESIGN AND METHODS: This randomized multicenter trial compared the safety and efficacy of a basal-bolus insulin regimen with glargine once daily and glulisine before meals (n = 104) to sliding scale regular insulin (SSI) four times daily (n = 107) in patients with type 2 diabetes mellitus undergoing general surgery. Outcomes included differences in daily blood glucose (BG) and a composite of postoperative complications including wound infection, pneumonia, bacteremia, and respiratory and acute renal failure. RESULTS: The mean daily glucose concentration after the 1st day of basal-bolus insulin and SSI was 145 ± 32 mg/dL and 172 ± 47 mg/dL, respectively (P < 0.01). Glucose readings <140 mg/dL were recorded in 55% of patients in basal-bolus and 31% in the SSI group (P < 0.001). There were reductions with basal-bolus as compared with SSI in the composite outcome [24.3 and 8.6%; odds ratio 3.39 (95% CI 1.50–7.65); P = 0.003]. Glucose <70 mg/dL was reported in 23.1% of patients in the basal-bolus group and 4.7% in the SSI group (P < 0.001), but there were no significant differences in the frequency of BG <40 mg/dL between groups (P = 0.057). CONCLUSIONS: Basal-bolus treatment with glargine once daily plus glulisine before meals improved glycemic control and reduced hospital complications compared with SSI in general surgery patients. Our study indicates that a basal-bolus insulin regimen is preferred over SSI in the hospital management of general surgery patients with type 2 diabetes.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures

Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“As discussed in Q12. How can glycemic targets be achieved in persons with T2D? as well as in the AACE Comprehensive Type 2 Diabetes Management Algorithm,73 some newer therapies carry a lower risk of hypoglycemia, which may enable more persons to safely achieve individualized target A1C levels.69,88–90”
From American Association of Clinical Endocrinology Clinical Practice Guideline: Developing a Diabetes Mellitus Comprehensive Care Plan-2022 Update. (2022) · cites this paper as [90]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“A randomized controlled trial has shown that basal plus bolus insulin plan improved glycemic outcomes and reduced hospital complications compared with a correction or supplemental insulin without basal insulin (formerly known as sliding scale) for people with type 2 diabetes admitted for general surgery (74).”
From 16. Diabetes Care in the Hospital: Standards of Care in Diabetes—2026 (2026) · cites this paper as [74]
The cited source says what the claim attributes to it.
In the citing paper
“In individuals undergoing noncardiac general surgery, basal insulin plus premeal short-or rapid-acting insulin (basal-bolus) coverage has been associated with improved glycemic outcomes and lower rates of perioperative complications compared with the reactive, correction-only short-or rapid-acting insulin coverage alone with no basal insulin dosing (74,145).”
From 16. Diabetes Care in the Hospital: Standards of Care in Diabetes—2026 (2026) · cites this paper as [74]
The check wasn’t confident either way, so it gives no verdict — never disputed.
In the citing paper
“Intensive glucose control (A1C levels <7% in T2D and <7.5% in T1D) in several clinical trials was found to reduce the risk of incident albuminuria (A2) and DKD onset.70,78,90,406–410”
From American Association of Clinical Endocrinology Clinical Practice Guideline: Developing a Diabetes Mellitus Comprehensive Care Plan-2022 Update. (2022) · cites this paper as [90]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Intensive insulin therapy in critically ill patients.
Van den Berghe, G., Wouters, P., Weekers, F., Verwaest, C., Bruyninckx, F., Schetz, M., Vlasselaers, D., Ferdinande, P., Lauwers, P., & Bouillon, R. (2001) · New England Journal of Medicine · doi:10.1056/nejmoa011300 · Cited by 9,977
Intensive insulin therapy in the medical ICU
Van den Berghe, G., Wilmer, A., Hermans, G., Meersseman, W., Wouters, P. J., Milants, I., Van Wijngaerden, E., Bobbaers, H., & Bouillon, R. (2006) · New England Journal of Medicine · doi:10.1056/nejmoa052521 · Cited by 3,639 · cited 1×
“…setting, observational and prospective clinical trials have shown that hyper-glycemia is associated with increased rates of hospital complications and mortality (8,10,11) and that improved glycemic control reduces multiorgan failure, systemic infections, and short-and long-term mortality (7,8).”
BackgroundHyperglycemia: an independent marker of in-hospital mortality in patients with undiagnosed diabetes
Umpierrez, G. E., Isaacs, S. D., Bazargan, N., You, X., Thaler, L. M., & Kitabchi, A. E. (2002) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.87.3.8341 · Cited by 2,195
Self-citationManagement of diabetes and hyperglycemia in hospitals.
Clement, S., Braithwaite, S. S., Magee, M. F., Ahmann, A., Smith, E. P., Schafer, R. G., Hirsch, I. B., & on behalf of the Diabetes in Hospitals Writing Committee (2004) · Diabetes Care · doi:10.2337/diacare.27.2.553 · Cited by 1,266
Furnary, A. P., Gao, G., Grunkemeier, G. L., Wu, Y., Zerr, K. J., Bookin, S. O., Floten, H. S., & Starr, A. (2003) · The Journal of Thoracic and Cardiovascular Surgery · doi:10.1067/mtc.2003.181 · Cited by 1,130
Lazar, H. L., Chipkin, S. R., Fitzgerald, C. A., Bao, Y., Cabral, H., & Apstein, C. S. (2004) · Circulation · doi:10.1161/01.cir.0000121747.71054.79 · Cited by 717
Early Postoperative Glucose Control Predicts Nosocomial Infection Rate in Diabetic Patients
Pomposelli, J. J., Baxter, J. K., Babineau, T. J., Pomfret, E. A., Driscoll, D. F., Forse, R. A., & Bistrian, B. R. (1998) · Journal of Parenteral and Enteral Nutrition · doi:10.1177/014860719802200277 · Cited by 700 · cited 2×
“7 times increased rate of infection (13).”
BackgroundUmpierrez, G. E., Smiley, D., Zisman, A., Prieto, L. M., Palacio, A., Ceron, M., Puig, A., & Mejia, R. (2007) · Diabetes Care · doi:10.2337/dc07-0295 · Cited by 671
Self-citationHyperglycemic Crises in Adult Patients With Diabetes
Kitabchi, A. E., Umpierrez, G. E., Murphy, M. B., & Kreisberg, R. A. (2006) · Diabetes Care · doi:10.2337/dc06-9916 · Cited by 512
Self-citationManagement of Hyperglycemia in the Hospital Setting
Inzucchi, S. E. (2006) · New England Journal of Medicine · doi:10.1056/nejmcp060094 · Cited by 391
Cited by
Standards of medical care in diabetes—2014
American Diabetes Association (2014) · Diabetes Care · doi:10.2337/dc14-s014 · Cited by 4,572
“outcomes in general surgery patients with type 2 diabetes (568).”
BackgroundStandards of medical care in diabetes—2013
American Diabetes Association (2013) · Diabetes Care · doi:10.2337/dc13-s011 · Cited by 4,369
“Prolonged therapy with sliding-scale insulin (SSI) as the sole regimen is ineffective in the majority of patients, increases risk of both hypoglycemia and hyperglycemia, and has recently been shown in a randomized trial to be associated with adverse outcomes in general surgery patients with type 2 diabetes (475).”
BackgroundStandards of medical care in diabetes—2011
American Diabetes Association (2011) · Diabetes Care · doi:10.2337/dc11-s011 · Cited by 2,880
Standards of Medical Care in Diabetes—2012
(2012) · Diabetes Care · doi:10.2337/dc12-s011 · Cited by 2,240
Nygren, J., Thacker, J., Carli, F., Fearon, K. C. H., Norderval, S., Lobo, D. N., Ljungqvist, O., Soop, M., & Ramirez, J. (2013) · World Journal of Surgery · doi:10.1007/s00268-012-1787-6 · Cited by 2,171
“Basal-bolus subcutaneous insulin therapy was shown to result in better glycaemic control and lower overall complication rates in diabetic, non-critically ill surgical patients in a recent randomised trial [122].”
BackgroundStrategies to Prevent Surgical Site Infections in Acute Care Hospitals: 2014 Update
Anderson, D. J., Podgorny, K., Berríos-Torres, S. I., Bratzler, D. W., Dellinger, E. P., Greene, L., Nyquist, A.-C., Saiman, L., Yokoe, D. S., Maragakis, L. L., et al. (2014) · Infection Control & Hospital Epidemiology · doi:10.1086/676022 · Cited by 1,216
Umpierrez, G. E., Hellman, R., Korytkowski, M. T., Kosiborod, M., Maynard, G. A., Montori, V. M., Seley, J. J., & Van den Berghe, G. (2012) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2011-2098 · Cited by 1,126
“The safety of scheduled basal bolus insulin in patients with either newly recognized hyperglycemia or type 2 diabetes has been demonstrated in several studies of noncritically ill hospitalized patients (33, 35, 69, 74).”
BackgroundMethodInfluentialSelf-citationGustafsson, U. O., Scott, M. J., Schwenk, W., Demartines, N., Roulin, D., Francis, N., McNaught, C. E., MacFie, J., Liberman, A. S., Soop, M., et al. (2012) · Clinical Nutrition · doi:10.1016/j.clnu.2012.08.013 · Cited by 839
ATUALIZAÇÃO DA DIRETRIZ BRASILEIRA DE DISLIPIDEMIAS E PREVENÇÃO DA ATEROSCLEROSE - 2017
Faludi, A., Izar, M., Saraiva, J., Chacra, A., Bianco, H., Afiune Neto, A., Bertolami, A., Pereira, A., Lottenberg, A., Sposito, A., et al. (2017) · Arquivos Brasileiros de Cardiologia · doi:10.5935/abc.20170121 · Cited by 633
Handelsman, Y., Bloomgarden, Z. T., Grunberger, G., Umpierrez, G., Zimmerman, R. S., Bailey, T. S., Blonde, L., Bray, G. A., Cohen, A. J., Dagogo-Jack, S., et al. (2015) · Endocrine Practice · doi:10.4158/ep15672.gl · Cited by 629
Self-citationKwon, S., Thompson, R., Dellinger, P., Yanez, D., Farrohki, E., & Flum, D. (2013) · Annals of Surgery · doi:10.1097/sla.0b013e31827b6bbc · Cited by 598
Treatment of Diabetes in Older Adults: An Endocrine Society* Clinical Practice Guideline
LeRoith, D., Biessels, G. J., Braithwaite, S. S., Casanueva, F. F., Draznin, B., Halter, J. B., Hirsch, I. B., McDonnell, M. E., Molitch, M. E., Murad, M. H., et al. (2019) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2019-00198 · Cited by 568
“(450) demonstrated that basalbolus insulin not only improved glycemic control but also significantly reduced hospital complications.”
BackgroundDiabetic emergencies - ketoacidosis, hyperglycaemic hyperosmolar state and hypoglycaemia
Umpierrez, G., & Korytkowski, M. (2016) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2016.15 · Cited by 563
Self-citationHandelsman, Y., Bloomgarden, Z. T., Grunberger, G., Umpierrez, G., Zimmerman, R. S., Bailey, T. S., Blonde, L., Bray, G. A., Cohen, A. J., Dagogo-Jack, S., et al. (2015) · Endocrine Practice · doi:10.4158/ep15672.glsuppl · Cited by 559
Self-citationBlonde, L., Umpierrez, G. E., Reddy, S. S., McGill, J. B., Berga, S. L., Bush, M., Chandrasekaran, S., DeFronzo, R. A., Einhorn, D., Galindo, R. J., et al. (2022) · Endocrine Practice · doi:10.1016/j.eprac.2022.08.002 · Cited by 507
Self-citation16. Diabetes Care in the Hospital: Standards of Medical Care in Diabetes—2022
American Diabetes Association Professional Practice Committee (2022) · Diabetes Care · doi:10.2337/dc22-s016 · Cited by 440
“In noncardiac general surgery patients, basal insulin plus premeal short- or rapid-acting insulin (basal-bolus) coverage has been associated with improved glycemic control and lower rates of perioperative complications compared with the reactive, sliding scale regimens (short- or rapid-acting insulin coverage only wit…”
BackgroundPerioperative Hyperglycemia Management: An Update
Duggan, E. W., Carlson, K., & Umpierrez, G. E. (2017) · Anesthesiology · doi:10.1097/aln.0000000000001515 · Cited by 402
“67 NPH and regular insulin, or premixed (70/30) formulations, demonstrate equivalent BG control when compared to basal bolus regimens, but are associated with higher rates of hypoglycemia in patients with poor oral intake.”
BackgroundSelf-citationStrategies to Prevent Surgical Site Infections in Acute Care Hospitals: 2014 Update
Anderson, D. J., Podgorny, K., Berríos-Torres, S. I., Bratzler, D. W., Dellinger, E. P., Greene, L., Nyquist, A.-C., Saiman, L., Yokoe, D. S., Maragakis, L. L., et al. (2014) · Infection Control & Hospital Epidemiology · doi:10.1017/s0899823x00193869 · Cited by 369
Nygren, J., Thacker, J., Carli, F., Fearon, K. C. H., Norderval, S., Lobo, D. N., Ljungqvist, O., Soop, M., & Ramirez, J. (2012) · Clinical Nutrition · doi:10.1016/j.clnu.2012.08.012 · Cited by 366
Management of diabetes and hyperglycaemia in the hospital
Pasquel, F. J., Lansang, M. C., Dhatariya, K., & Umpierrez, G. E. (2021) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(20)30381-8 · Cited by 329
Self-citationKorytkowski, M. T., Muniyappa, R., Antinori-Lent, K., Donihi, A. C., Drincic, A. T., Hirsch, I. B., Luger, A., McDonnell, M. E., Murad, M. H., Nielsen, C., et al. (2022) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgac278 · Cited by 315
Self-citationStrategies to prevent surgical site infections in acute-care hospitals: 2022 Update
Calderwood, M. S., Anderson, D. J., Bratzler, D. W., Dellinger, E. P., Garcia-Houchins, S., Maragakis, L. L., Nyquist, A.-C., Perkins, K. M., Preas, M. A., Saiman, L., et al. (2023) · Infection Control & Hospital Epidemiology · doi:10.1017/ice.2023.67 · Cited by 307
Umpierrez, G., Cardona, S., Pasquel, F., Jacobs, S., Peng, L., Unigwe, M., Newton, C. A., Smiley-Byrd, D., Vellanki, P., Halkos, M., et al. (2015) · Diabetes Care · doi:10.2337/dc15-0303 · Cited by 281
Self-citation15. Diabetes Care in the Hospital: Standards of Medical Care in Diabetes—2020
American Diabetes Association (2020) · Diabetes Care · doi:10.2337/dc20-s015 · Cited by 265
“, dosing given in response to elevated glucose rather than pre-emptively) in general surgery patients with type 2 diabetes (48).”
BackgroundDiabetes Technology Update: Use of Insulin Pumps and Continuous Glucose Monitoring in the Hospital
Umpierrez, G. E., & Klonoff, D. C. (2018) · Diabetes Care · doi:10.2337/dci18-0002 · Cited by 251
“in improving glycemic control and in reducing the risk of hospital complications (6,7), intensive insulin therapy results in frequent hypoglycemia, reported in 12–30% of patients (8–10).”
BackgroundSelf-citationGlucocorticoid‐induced hyperglycemia (糖皮质激素诱导的高血糖)
Perez, A., Jansen‐Chaparro, S., Saigi, I., Bernal‐Lopez, M. R., Miñambres, I., & Gomez‐Huelgas, R. (2014) · Journal of Diabetes · doi:10.1111/1753-0407.12090 · Cited by 240
Closed-loop insulin delivery for glycemic control in noncritical care
Bally, L., Thabit, H., Hartnell, S., Andereggen, E., Ruan, Y., Wilinska, M. E., Evans, M. L., Wertli, M. M., Coll, A. P., Stettler, C., et al. (2018) · New England Journal of Medicine · doi:10.1056/nejmoa1805233 · Cited by 232
Umpierrez, G. E., Smiley, D., Hermayer, K., Khan, A., Olson, D. E., Newton, C., Jacobs, S., Rizzo, M., Peng, L., Reyes, D., et al. (2013) · Diabetes Care · doi:10.2337/dc12-1988 · Cited by 222
Self-citation16. Diabetes Care in the Hospital: Standards of Care in Diabetes—2023
ElSayed, N. A., Aleppo, G., Aroda, V. R., Bannuru, R. R., Brown, F. M., Bruemmer, D., Collins, B. S., Hilliard, M. E., Isaacs, D., Johnson, E. L., et al. (2023) · Diabetes Care · doi:10.2337/dc23-s016 · Cited by 221
15. Diabetes Care in the Hospital: Standards of Medical Care in Diabetes—2019
American Diabetes Association (2019) · Diabetes Care · doi:10.2337/dc19-s015 · Cited by 216
“In noncardiac general surgery patients, basal insulin plus premeal short- or rapidacting insulin (basal-bolus) coverage has been associated with improved glycemic control and lower rates of perioperative complications compared with the traditional sliding scale regimen (short- or rapid-acting insulin coverage only wit…”
Background15. Diabetes Care in the Hospital: Standards of Medical Care in Diabetes—2021
American Diabetes Association (2021) · Diabetes Care · doi:10.2337/dc21-s015 · Cited by 197
“, dosing given in response to elevated glucose rather than preemptively) in general surgery patients with type 2 diabetes (47).”
Background16. Diabetes Care in the Hospital: Standards of Care in Diabetes—2025
American Diabetes Association Professional Practice Committee, ElSayed, N. A., McCoy, R. G., Aleppo, G., Balapattabi, K., Beverly, E. A., Briggs Early, K., Bruemmer, D., Echouffo-Tcheugui, J. B., Ekhlaspour, L., et al. (2025) · Diabetes Care · doi:10.2337/dc25-s016 · Cited by 195
Glycemic Control in Non-Critically Ill Hospitalized Patients: A Systematic Review and Meta-Analysis
Murad, M. H., Coburn, J. A., Coto-Yglesias, F., Dzyubak, S., Hazem, A., Lane, M. A., Prokop, L. J., & Montori, V. M. (2012) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2011-2100 · Cited by 192
14. Diabetes Care in the Hospital: Standards of Medical Care in Diabetes—2018
American Diabetes Association (2018) · Diabetes Care · doi:10.2337/dc18-s014 · Cited by 178
Peden, C. J., Aggarwal, G., Aitken, R. J., Anderson, I. D., Bang Foss, N., Cooper, Z., Dhesi, J. K., French, W. B., Grant, M. C., Hammarqvist, F., et al. (2021) · World Journal of Surgery · doi:10.1007/s00268-021-05994-9 · Cited by 171
Pasquel, F. J., Gianchandani, R., Rubin, D. J., Dungan, K. M., Anzola, I., Gomez, P. C., Peng, L., Hodish, I., Bodnar, T., Wesorick, D., et al. (2017) · The Lancet Diabetes & Endocrinology · doi:10.1016/s2213-8587(16)30402-8 · Cited by 168
Self-citation16. Diabetes Care in the Hospital: Standards of Care in Diabetes—2024
American Diabetes Association Professional Practice Committee, ElSayed, N. A., Aleppo, G., Bannuru, R. R., Bruemmer, D., Collins, B. S., Ekhlaspour, L., Galindo, R. J., Hilliard, M. E., Johnson, E. L., et al. (2024) · Diabetes Care · doi:10.2337/dc24-s016 · Cited by 167
de Vries, F. E. E., Gans, S. L., Solomkin, J. S., Allegranzi, B., Egger, M., Dellinger, E. P., & Boermeester, M. A. (2016) · British journal of surgery · doi:10.1002/bjs.10424 · Cited by 184
Umpierrez, G. E., Gianchandani, R., Smiley, D., Jacobs, S., Wesorick, D. H., Newton, C., Farrokhi, F., Peng, L., Reyes, D., Lathkar-Pradhan, S., et al. (2013) · Diabetes Care · doi:10.2337/dc13-0277 · Cited by 166
“As previously reported (11,14), we show that the use of basal insulin as part of a basal bolus regimen or in combination with sitagliptin is well tolerated with a low rate of hypoglycemia.”
Self-citationManagement of Hyperglycemia During Enteral and Parenteral Nutrition Therapy
Gosmanov, A. R., & Umpierrez, G. E. (2013) · Current Diabetes Reports · doi:10.1007/s11892-012-0335-y · Cited by 166
Self-citationManagement of Inpatient Hyperglycemia and Diabetes in Older Adults
Umpierrez, G. E., & Pasquel, F. J. (2017) · Diabetes Care · doi:10.2337/dc16-0989 · Cited by 159
“Several studies have shown that basal-bolus regimen results in better glycemic control and in lower rates of perioperative complications compared with sliding scale insulin therapy alone (11,38).”
BackgroundResultSelf-citationSpanakis, E. K., Urrutia, A., Galindo, R. J., Vellanki, P., Migdal, A. L., Davis, G., Fayfman, M., Idrees, T., Pasquel, F. J., Coronado, W. Z., et al. (2022) · Diabetes Care · doi:10.2337/dc22-0716 · Cited by 153
Self-citationPathways to Quality Inpatient Management of Hyperglycemia and Diabetes: A Call to Action
Draznin, B., Gilden, J., Golden, S. H., Inzucchi, S. E., & for the PRIDE investigators (2013) · Diabetes Care · doi:10.2337/dc12-2508 · Cited by 145
“An effective solution to the use of sliding scale insulin is the development and implementation of policies, protocols, and order sets for scheduled insulin administration in various clinical situations, as was demonstrated by the RABBIT (RAndomized Study of Basal-Bolus Insulin Therapy) studies (31,32).”
MethodGlycemic control in non-diabetic critically ill patients
Farrokhi, F., Smiley, D., & Umpierrez, G. E. (2011) · Best Practice & Research Clinical Endocrinology & Metabolism · doi:10.1016/j.beem.2011.05.004 · Cited by 138
Self-citationInpatient Management of Diabetic Foot Disorders: A Clinical Guide
Wukich, D. K., Armstrong, D. G., Attinger, C. E., Boulton, A. J. M., Burns, P. R., Frykberg, R. G., Hellman, R., Kim, P. J., Lipsky, B. A., Pile, J. C., et al. (2013) · Diabetes Care · doi:10.2337/dc12-2712 · Cited by 140
“There is now unequivocal evidence from randomized studies that hyperglycemia in hospitals is associated with adverse outcomes (15,53,54).”
BackgroundMifsud, S., Schembri, E. L., & Gruppetta, M. (2018) · British Journal of Hospital Medicine · doi:10.12968/hmed.2018.79.11.634 · Cited by 150
Scott, M. J., Aggarwal, G., Aitken, R., Anderson, I. D., Balfour, A., Foss, N. B., Cooper, Z. R., Dhesi, J. K., French, W. B., Grant, M. C., et al. (2023) · World Journal of Surgery · doi:10.1007/s00268-023-07020-6 · Cited by 161
“Treatment with insulin to reduce hyperglycemia can reduce complications [166].”
BackgroundCrowley, K., Scanaill, P. Ó., Hermanides, J., & Buggy, D. J. (2023) · British Journal of Anaesthesia · doi:10.1016/j.bja.2023.02.039 · Cited by 148
“001) in the perioperative management of glycaemic control, also showing a reduction of postoperative complications.(46) However, it has been demonstrated in other studies that over-zealous control of blood glucose can lead to harmful outcomes such as hypoglycaemia and increased morbidity and mortality.”
ResultUmpierrez, G. E., Reyes, D., Smiley, D., Hermayer, K., Khan, A., Olson, D. E., Pasquel, F., Jacobs, S., Newton, C., Peng, L., et al. (2014) · Diabetes Care · doi:10.2337/dc14-0479 · Cited by 130
Self-citationMortality among hospitalized patients with hypoglycemia: insulin related and noninsulin related
Akirov, A., Grossman, A., Shochat, T., & Shimon, I. (2017) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2016-2653 · Cited by 127
Fortmann, A. L., Bagsic, S. R. S., Talavera, L., Garcia, I. M., Sandoval, H., Hottinger, A., & Philis‐Tsimikas, A. (2020) · Diabetes Care · doi:10.2337/dc20-1016 · Cited by 127
Insulin Therapy for the Management of Hyperglycemia in Hospitalized Patients
McDonnell, M. E., & Umpierrez, G. E. (2012) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/j.ecl.2012.01.001 · Cited by 117
“…patients, the recent RAndomized Study of Basal Bolus Insulin Therapy in the Inpatient Management of Patients with Type 2 Diabetes Undergoing General Surgery (RABBIT 2 Surgery) trial 154 compared the efficacy and safety of basal bolus regimen to SSI in 211 patients with type 2 diabetes mellitus.”
BackgroundMethodInfluentialSelf-citationManagement of Hyperglycemia and Diabetes in Orthopedic Surgery
Akiboye, F., & Rayman, G. A. (2017) · Current Diabetes Reports · doi:10.1007/s11892-017-0839-6 · Cited by 137
Bellido, V., Suarez, L., Rodriguez, M. G., Sanchez, C., Dieguez, M., Riestra, M., Casal, F., Delgado, E., Menendez, E., & Umpierrez, G. E. (2015) · Diabetes Care · doi:10.2337/dc15-0160 · Cited by 118
Self-citationSteroid-induced hyperglycemia: An underdiagnosed problem or clinical inertia? A narrative review
Bonaventura, A., & Montecucco, F. (2018) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2018.03.006 · Cited by 108
González-Campoy, J. M., CASTORINO, K. N., Ebrahim, A., Hurley, D., Jovanovič, L., Mechanick, J. I., Petak, S. M., Yu, Y., Jeor, S. T. S., Harris, K. A., et al. (2013) · Endocrine Practice · doi:10.4158/ep13155.gl · Cited by 154
Baldwin, D., Zander, J., Munoz, C., Raghu, P., DeLange-Hudec, S., Lee, H., Emanuele, M. A., Glossop, V., Smallwood, K., & Molitch, M. (2012) · Diabetes Care · doi:10.2337/dc12-0578 · Cited by 103
Garg, R., Schuman, B., Bader, A., Hurwitz, S., Turchin, A., Underwood, P., Metzger, C., Rein, R., & Lortie, M. (2018) · Annals of Surgery · doi:10.1097/sla.0000000000002323 · Cited by 103
González-Campoy, J. M., Jeor, S. T. S., CASTORINO, K. N., Ebrahim, A., Hurley, D., Jovanovič, L., Mechanick, J. I., Petak, S. M., Yu, Y., Harris, K. A., et al. (2013) · Endocrine Practice · doi:10.4158/ep13155.esgl · Cited by 103
Reducing the risk of infection after total joint arthroplasty: preoperative optimization
Antonelli, B. J., & Chen, A. F. (2019) · Arthroplasty · doi:10.1186/s42836-019-0003-7 · Cited by 109
Conlin, P. R., Colburn, J., Aron, D., Pries, R. M., Tschanz, M. P., & Pogach, L. (2017) · Annals of Internal Medicine · doi:10.7326/m17-1362 · Cited by 97
“Use of basal–bolus insulin also reduced risk for postsurgical complications (51).”
BackgroundWexler, D. J., Beauharnais, C. C., Regan, S., Nathan, D. M., Cagliero, E., & Larkin, M. E. (2012) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2012.09.016 · Cited by 89
“It has now been established that notwithstanding the controversy over intensive glycemic control in ICU patients [2], good glycemic control remains an important goal among all hospitalized patients [3] and can be achieved safely in general medical and surgical settings [4, 5].”
BackgroundPerioperative management of hyperglycemia and diabetes in cardiac surgery patients
Galindo, R. J., Fayfman, M., & Umpierrez, G. E. (2018) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/j.ecl.2017.10.005 · Cited by 95
Self-citationComplication Rates of Ostomy Surgery Are High and Vary Significantly Between Hospitals
Sheetz, K. H., Waits, S. A., Krell, R. W., Morris, A. M., Englesbe, M. J., Mullard, A. J., Campbell, D. A., & Hendren, S. K. (2014) · Diseases of the Colon & Rectum · doi:10.1097/dcr.0000000000000038 · Cited by 93
14. Diabetes Care in the Hospital
American Diabetes Association (2016) · Diabetes Care · doi:10.2337/dc17-s017 · Cited by 110
“In noncardiac general surgery patients, basal insulin plus premeal regular or short-acting insulin (basal-bolus) coverage has been associated with improved glycemic control and lower rates of perioperative complications compared with the traditional sliding scale regimen (regular or short-acting insulin coverage only…”
Background13. Diabetes Care in the Hospital
American Diabetes Association (2015) · Diabetes Care · doi:10.2337/dc16-s016 · Cited by 103
“Control Targets In general surgery (noncardiac) patients, basal insulin plus premeal regular or short-acting insulin (basal–bolus) coverage has been associated with improved glycemic control and lower rates of perioperative complications compared with the traditional sliding scale regimen (regular or short-acting insu…”
BackgroundUnderstanding hypoglycemia in hospitalized patients
Hulkower, R. D., Pollack, R. M., & Zonszein, J. (2014) · Diabetes Management · doi:10.2217/dmt.13.73 · Cited by 89
A Pragmatic Approach to Inpatient Diabetes Management during the COVID-19 Pandemic
Korytkowski, M., Antinori-Lent, K., Drincic, A., Hirsch, I. B., McDonnell, M. E., Rushakoff, R., & Muniyappa, R. (2020) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgaa342 · Cited by 89
“Implementation of protocols to control BG levels while also avoiding hypoglycemia have the ability to reduce these adverse outcomes (8-10).”
BackgroundKyi, M., Colman, P. G., Wraight, P. R., Reid, J., Gorelik, A., Galligan, A., Kumar, S., Rowan, L. M., Marley, K. A., Nankervis, A. J., et al. (2019) · Diabetes Care · doi:10.2337/dc18-2342 · Cited by 86
“There is strongevidence that intensiveglycemic control decreases infections in cardiac and general surgery (33,34), critical care (35), and noncritical care (7,36).”
BackgroundA Consensus Statement for Continuous Glucose Monitoring Metrics for Inpatient Clinical Trials
Spanakis, E. K., Cook, C. B., Kulasa, K. M., Aloi, J., Bally, L., Davis, G. M., Dungan, K. M., Galindo, R. J., Mendez, C. E., Pasquel, F. J., et al. (2023) · Journal of Diabetes Science and Technology · doi:10.1177/19322968231191104 · Cited by 92
Self-citationFayfman, M., Galindo, R. J., Rubin, D. J., Mize, D. L., Anzola, I., Urrutia, M. A., Ramos, C., Pasquel, F. J., Haw, J. S., Vellanki, P., et al. (2019) · Diabetes Care · doi:10.2337/dc18-1760 · Cited by 85
Self-citationEpigenetic modification and therapeutic targets of diabetes mellitus
Singh, R., Chandel, S., Dey, D., Ghosh, A., Roy, S., Ravichandiran, V., & Ghosh, D. (2020) · Bioscience Reports · doi:10.1042/bsr20202160 · Cited by 88
Hypoglycemia in Hospitalized Patients Treated with Sulfonylureas
Deusenberry, C. M., Coley, K. C., Korytkowski, M. T., & Donihi, A. C. (2012) · Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy · doi:10.1002/j.1875-9114.2011.01088.x · Cited by 86
Burt, M. G., Roberts, G. W., Aguilar-Loza, N. R., & Stranks, S. N. (2013) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2012.0282 · Cited by 83
Vellanki, P., Rasouli, N., Baldwin, D., Alexanian, S., Anzola, I., Urrutia, M., Cardona, S., Peng, L., Pasquel, F. J., Umpierrez, G. E., et al. (2019) · Diabetes, Obesity and Metabolism · doi:10.1111/dom.13587 · Cited by 80
“The percentage of participants with hypoglycaemia in the basal-bolus group in the current study was lower than that in our previous studies in which the rate of hypoglycaemia ranged from 16% to 23%.(15,22,23) In our current study, despite receiving similar amounts of supplemental insulin, only two participants in the…”
Self-citation16. Diabetes Care in the Hospital: Standards of Care in Diabetes—2026
American Diabetes Association Professional Practice Committee for Diabetes*, Bajaj, M., McCoy, R. G., Balapattabi, K., Bannuru, R. R., Bellini, N. J., Bennett, A. K., Beverly, E. A., Briggs Early, K., ChallaSivaKanaka, S., et al. (2026) · Diabetes Care · doi:10.2337/dc26-s016 · Cited by 80
3rd GUIDELINE FOR PERIOPERATIVE CARDIOVASCULAR EVALUATION OF THE BRAZILIAN SOCIETY OF CARDIOLOGY
Gualandro, D., Yu, P., Caramelli, B., Marques, A., Calderaro, D., Fornari, L. S., Pinho, C., Feitosa, A. K. N., Polanczyk, C. A., Rochitte, C. E., et al. (2017) · Arquivos Brasileiros de Cardiologia · doi:10.5935/abc.20170140 · Cited by 90
Safety and efficacy of saxagliptin for glycemic control in non-critically ill hospitalized patients
Garg, R., Schuman, B., Hurwitz, S., Metzger, C., & Bhandari, S. (2017) · BMJ Open Diabetes Research & Care · doi:10.1136/bmjdrc-2017-000394 · Cited by 79
The clinical impact of inpatient hypoglycemia
Brutsaert, E. F., Carey, M., & Zonszein, J. (2014) · Journal of Diabetes and its Complications · doi:10.1016/j.jdiacomp.2014.03.002 · Cited by 78
“For example, hypoglycemia defined as a point-of-care glucose ≤ 70 mg/dL was reported in 23% of surgical patients with type 2 diabetes (T2DM) receiving a basal-bolus insulin regimen (Umpierrez et al., 2011).”
BackgroundFarrokhi, F., Klindukhova, O., Chandra, P., Peng, L., Smiley, D. D., Newton, C. A., Pasquel, F. J., Fereira, M. E., & Umpierrez, G. E. (2012) · Journal of Diabetes Science and Technology · doi:10.1177/193229681200600505 · Cited by 79
Self-citationHulst, A. H., Visscher, M. J., Godfried, M. B., Thiel, B., Gerritse, B. M., Scohy, T. V., Bouwman, R. A., Willemsen, M. G. A., Hollmann, M. W., Preckel, B., et al. (2020) · Diabetes, Obesity and Metabolism · doi:10.1111/dom.13927 · Cited by 75
Expert consensus on the glycemic management of critically ill patients
Wu, Z., Liu, J., Zhang, D., Kang, K., Zuo, X., Xu, Q., Pan, A., Fang, W., Liu, F., Shang, Y., et al. (2022) · Journal of Intensive Medicine · doi:10.1016/j.jointm.2022.06.001 · Cited by 73
Lutfiyya, W. L., Parsons, D. P., & Breen, J. (2012) · The Permanente Journal · doi:10.7812/tpp/12.968 · Cited by 76
Spanakis, E. K., Levitt, D. L., Siddiqui, T., Singh, L. G., Pinault, L. F., Sorkin, J. D., Umpierrez, G. E., & Fink, J. C. (2017) · Journal of Diabetes Science and Technology · doi:10.1177/1932296817748964 · Cited by 75
Self-citationPerioperative Glucose Control in Patients With Diabetes Undergoing Elective Surgery
Simha, V., & Shah, P. (2019) · JAMA · doi:10.1001/jama.2018.20922 · Cited by 71
Seisa, M. O., Saadi, S., Nayfeh, T., Muthusamy, K., Shah, S. H., Firwana, M., Hasan, B., Jawaid, T., Abd-Rabu, R., Korytkowski, M. T., et al. (2022) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgac277 · Cited by 65
Management of hyperglycemia in hospitalized patients
Smiley, D., & Umpierrez, G. E. (2010) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2010.05805.x · Cited by 64
Self-citationPolderman, J. A. W., van Steen, S. C. J., Thiel, B., Godfried, M. B., Houweling, P. L., Hollmann, M. W., DeVries, J. H., Preckel, B., & Hermanides, J. (2018) · Anaesthesia · doi:10.1111/anae.14180 · Cited by 63
“Apart from the longer treatment period (nine days) in a recent trial [22], this discrepancy could be due to several reasons; although the insulin infusion and insulin bolus groups had higher plasma glucose values than the liraglutide group, we were able to prevent the first hyperglycaemic peak after surgery in all thr…”
BackgroundResultFaludi, A., Izar, M., Saraiva, J., Bianco, H. T., Chacra, A., Bertoluci, M., Moreira, R., Turatti, L., Bertolami, A., Sulzbach, M. L., et al. (2017) · Arquivos Brasileiros de Cardiologia · doi:10.5935/abc.20170188 · Cited by 107
Inpatient Management of Diabetes and Hyperglycemia
Bogun, M. M., & Inzucchi, S. E. (2013) · Clinical Therapeutics · doi:10.1016/j.clinthera.2013.04.008 · Cited by 67
Richards, J. E., Hutchinson, J. R., Mukherjee, K., Jahangir, A. A., Mir, H. R., Evans, J. M., Perdue, A. M., Obremskey, W. T., Sethi, M. K., & May, A. K. (2014) · The Journal of Trauma: Injury, Infection, and Critical Care · doi:10.1097/ta.0000000000000177 · Cited by 68
Peralta, F. G., Abreu, C., Rodríguez, S. G., Barranco, R. J., & Umpierrez, G. E. (2018) · Diabetes Therapy · doi:10.1007/s13300-018-0488-z · Cited by 68
“However, basal-bolus insulin regimens require multiple daily insulin injections and carry a substantial risk of hypoglycemia, reported in up to 32% of non-ICU patients with T2D [65].”
BackgroundSelf-citation13. Diabetes Care in the Hospital, Nursing Home, and Skilled Nursing Facility
American Diabetes Association (2014) · Diabetes Care · doi:10.2337/dc15-s016 · Cited by 66
Perioperative Evaluation and Management of Endocrine Disorders
Himes, C. P., Ganesh, R., Wight, E. C., Simha, V., & Liebow, M. (2020) · Mayo Clinic Proceedings · doi:10.1016/j.mayocp.2020.05.004 · Cited by 65
In-hospital Management of Diabetes
Houlden, R. L., Capes, S. E., CLEMENT, M. A., & Miller, D. B. (2013) · Canadian Journal of Diabetes · doi:10.1016/j.jcjd.2013.01.024 · Cited by 64
Aidar, R. G., Salil, G., Sundae, S., Limin, P., & Umpierrez, G. E. (2013) · Endocrine Practice · doi:10.4158/ep12256.or · Cited by 59
“In contrast, basal-bolus insulin (BBI) therapy is now the preferred regimen for insulin delivery in hospitalized patients with diabetes, but no systematic assessment of BBI in patients with steroid-induced hyperglycemia has been reported (1,5-7).”
BackgroundSelf-citationKang, S., Kang, S. M., Choi, J. H., Ko, S., Koo, B. K., Kwon, H.-S., Kim, M. K., Kim, S. Y., Kim, S., Kim, Y., et al. (2025) · Diabetes & Metabolism Journal · doi:10.4093/dmj.2025.0469 · Cited by 83
Management of Hyperglycemia and Enteral Nutrition in the Hospitalized Patient
Davidson, P., Kwiatkowski, C. A., & Wien, M. (2015) · Nutrition in Clinical Practice · doi:10.1177/0884533615591057 · Cited by 57
Bertoluci, M. C., Moreira, R. O., Faludi, A. Á., Izar, M. C. D. O., Schaan, B. D., Valério, C. M., Bertolami, M. C., Chacra, A. P. M., Malachias, M. V. B., Vencio, S. A. C., et al. (2017) · Diabetology & Metabolic Syndrome · doi:10.1186/s13098-017-0251-z · Cited by 69
“• A randomized controlled trial showed that basalbolus treatment (glargine and glulisine) improved glycemic control and reduced hospital complications (wound infection, pneumonia, acute renal failure, and bacteremia) compared with sliding-scale insulin (glulisine) in general surgery patients with type 2 diabetes [78].”
BackgroundChristensen, M. B., Gotfredsen, A., & Nørgaard, K. (2017) · Diabetes/Metabolism Research and Reviews · doi:10.1002/dmrr.2885 · Cited by 57
“In the RABBIT 2 Surgery study, basal‐bolus treatmentwas associatedwith significant reduction in postoperative complication as a composite including wound infection, pneumonia, bacteremia, respiratory failure, and acute renal failure.(11) In contrast, Schroeder et al found no difference in postoperative complication be…”
Background
Metadata
- Authors
- Umpierrez, G. E., Smiley, D., Jacobs, S., Peng, L., Temponi, A., Mulligan, P., Umpierrez, D., Newton, C., Olson, D., & Rizzo, M.
- Affiliations
- Grady Memorial Hospital (US)
- Emory University (US)
- Department of Medicine, Emory University, Atlanta, Georgia
- Corresponding author
- Umpierrez, Guillermo E.
- Venue
- Diabetes Care
- Publisher
- American Diabetes Association
- Published
- 2011-01-20
- Volume
- 34
- Issue
- 2
- Pages
- 256-261
- ISSN
- 0149-5992 (ISSN-L)
- 1935-5548
- PMC
- PMC3024330
- OpenAlex
- W2106327047
- Cited by
- 720
- References
- 24
- Citations by year
- 2026: 19 · 2025: 36 · 2024: 37 · 2023: 47 · 2022: 53 · 2021: 37 · 2020: 44 · 2019: 52 · 2018: 55 · 2017: 54 · 2016: 48 · 2015: 51 · 2014: 61 · 2013: 53 · 2012: 44
- FWCI
- 48.02
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- Locations
- Diabetes Care (publishedVersion, cc-by-nc-nd)
- Europe PMC (PubMed Central) (publishedVersion, cc-by-nc-nd)
- PubMed Central (publishedVersion, cc-by-nc-nd)
- PubMed (publishedVersion)
- Funders
- National Institutes of Health (UL1TR000454)
- National Institute of Diabetes and Digestive and Kidney Diseases (R03DK073190)
- National Center for Research Resources (M01-RR00039, K12RR017643, M01RR000039)
- National Center for Advancing Translational Sciences
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Hyperglycemia and glycemic control in critically ill and hospitalized patients
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Treatment and Management
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Management and Research
- Keywords
- type 2 diabetes, multiple daily insulin injections, glargine, glulisine, sliding scale insulin, general surgery, perioperative hyperglycemia, glycemic control, postoperative complications, wound infection, respiratory failure, acute kidney injury, bacteremia
- MeSH terms
- Insulin Glargine, Aged, Blood Glucose, Diabetes Mellitus, Type 2, Female, Humans, Hypoglycemic Agents, Inpatients, Insulin, Male, Middle Aged, Postoperative Complications, Prospective Studies, General Surgery, Perioperative Care, Insulin, Long-Acting
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.